Servier Symphogen A/S
CVR 10013267 · Public limited company (A/S) · Active · Low risk
Servier Symphogen A/S is a Public limited company (A/S), founded on , based in Ballerup. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published. The latest annual report (30 Sep 2025) shows equity of DKK 162.9m and a net result of DKK 39.1m.
Bankruptcy risk for Servier Symphogen A/S
0.0 × the average (1.41%) · higher risk than 18% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 10013267
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (26 years)
- Address
- Pederstrupvej 93
2750 Ballerup - Municipality
- Ballerup
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 11.3m
- Employees
- 150 (2018)
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 25 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 41.7% |
| Current ratio | 150% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 3 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 2 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Revenue | DKK 593.8m | DKK 474.7m |
| Gross profit | DKK 235.7m | DKK 220.6m |
| Net profit | DKK 39.1m | DKK 37.3m |
| Equity | DKK 162.9m | DKK 223.7m |
| Total assets | DKK 390.9m | DKK 422.8m |
| Cash | DKK 6.4m | – |
| Short-term debt | DKK 133.5m | – |
| Tax owed | DKK 2.1m | – |
| Avg. employees | 159 | – |
Latest annual report: Reporting class C, stor virksomhed · auditor's statement: Revisionspåtegning · EY Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Oct 2024 – 30 Sep 2025 | 178 | ||
| 1 Oct 2023 – 30 Sep 2024 | 176 | ||
| 1 Oct 2022 – 30 Sep 2023 | 177 | ||
| 1 Oct 2021 – 30 Sep 2022 | 180 | ||
| 1 Oct 2020 – 30 Sep 2021 | 110 | Restated | |
| 1 Jan 2019 – 31 Dec 2019 | 155 | ||
| 1 Jan 2018 – 31 Dec 2018 | 154 | ||
| 1 Jan 2017 – 31 Dec 2017 | 82 | ||
| 1 Jan 2016 – 31 Dec 2016 | 145 | ||
| 1 Jan 2015 – 31 Dec 2015 | 152 | ||
| 1 Jan 2014 – 31 Dec 2014 | 131 | ||
| 1 Jan 2013 – 31 Dec 2013 | 162 | ||
| 1 Jan 2012 – 31 Dec 2012 | 127 | ||
| 1 Jan 2011 – 31 Dec 2011 | 116 | ||
| 1 Jan 2010 – 31 Dec 2010 | 108 | ||
| 1 Jan 2009 – 31 Dec 2009 | 125 | ||
| 1 Jan 2008 – 31 Dec 2008 | 124 | ||
| 1 Jan 2007 – 31 Dec 2007 | 141 | ||
| 1 Jan 2006 – 31 Dec 2006 | 164 | ||
| 1 Jan 2005 – 31 Dec 2005 | 156 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Peter Andreas Stakemann | ||
| CEO | Kirsten Aarup Drejer | ||
| Board | Christophe Jacques Alain Henri Thurieau | Current | |
| Board | Claude Philippe Bertrand | Current | |
| Board | Benoit Alain Antoine Chéron | Current | |
| Board | Pascal Lemaire | Current | |
| Board | Anker Gunvald Lundemose | ||
| Board | Kim Arthur Hueg | ||
| Board | Eigil Bjerl Nielsen | ||
| Board | Søren Knud Carlsen | ||
| Board | Henrik Lawaetz | ||
| Board | Kirsten Aarup Drejer | ||
| Board | Martin Olin | ||
| Board | Jeff Himawan | ||
| Board | Kim Lennart Dueholm | ||
| Board | Laurence Jay Korn | ||
| Board | Jack Taaning Johansen | ||
| Board | Ian James Nicholson | ||
| Board | Martin William Edwards | ||
| Board | Göran Albert Torstensson Ando | ||
| Board | Tom Bork Petersen | ||
| Board | Jeppe Christiansen | ||
| Board | John Barry Landis | ||
| Board | Samuel Broder | ||
| Board | Anthony William Tolcher | ||
| Board | Annika Carin Margareta Espander Jansson | ||
| Board | Morten Aleksandr Engel | ||
| Board | Ronald Welcome Eastman | ||
| Board | Jess Christoffer Søderberg | ||
| Board | Jeffrey Howard Buchalter | ||
| Board | Martin Olin | ||
| Board | Anders Lennart Tullgren | ||
| Board | Søren Lemonius | ||
| Board | Peter Helt Jacobsen Haahr | ||
| Board | Mads Krogsgaard Thomsen | ||
| Board | Jeppe Christiansen | ||
| Board | Bernhard Rainer Maria Ehmer | ||
| Board | Dominique Jean-Claude Paul Brissy | ||
| Owner (100%) | Les Laboratoires Servier | Current | |
| Owner (5%) | ESSEX Woodlands Health Ventures Fund VI, LP | ||
| Owner (10%) | ESSEX Woodlands Health Ventures Fund V. LP | ||
| Owner (10%) | Lønmodtagernes Dyrtidsfond | ||
| Owner (5%) | PENSIONSKASSEN FOR SYGEPLEJERSKER OG LÆGESEKRETÆRER | ||
| Owner (20%) | Novo Holdings A/S | ||
| Owner (5%) | SUNSTONE LIFE SCIENCE VENTURES FUND I K/S | ||
| Owner (5%) | ESSEX Woodlands, fund VIII, LP | ||
| Owner (10%) | PENSIONSKASSEN FOR SYGEPLEJERSKER OG LÆGESEKRETÆRER | ||
| Owner (5%) | PENSIONSKASSEN FOR SUNDHEDSFAGLIGE | ||
| Owner (5%) | PENSIONSKASSEN FOR SOCIALRÅDGIVERE , SOCIALPÆDAGOGER OG KONTORPERSONALE | ||
| Owner (33%) | Novo Holdings A/S | ||
| Owner (10%) | SUNSTONE LIFE SCIENCE VENTURES FUND I K/S | ||
| Owner (10%) | ESSEX Woodlands, fund VIII, LP | ||
| Owner (90%) | Les Laboratoires Servier | ||
| Auditor | EY Godkendt Revisionspartnerselskab | Current | |
| Auditor | ERNST & YOUNG DENMARK P/S | ||
| Auditor | Søren Hedemand Jacobsen | ||
| Auditor | ERNST & YOUNG DENMARK P/S | ||
| Auditor | ERNST & YOUNG DENMARK P/S | ||
| Founder | ANPARTSSELSKABET STAKEMANN | Current |
The CEOs' other companies
Peter Andreas Stakemann – 54 other companies, of which 54 bankrupt
- 01-05-24 ApS Bankrupt 17 Mar 2025
- 061746M A/S Bankrupt 3 Oct 2011
- 1 STEP, COPENHAGEN LOGISTIC & DISTRIBUTION ApS Bankrupt 15 Jan 2009
- 1001 WATT ApS Bankrupt 29 Jan 2002
- 123 AF 04.07.2012 ApS Bankrupt 6 Aug 2012
- 1264 ApS Bankrupt 12 Jun 2012
- 1414 EJENDOMSINVEST 10 ApS Bankrupt 22 Dec 2015
- 1414 EJENDOMSINVEST 12 ApS Bankrupt 22 Dec 2015
- 1414 EJENDOMSINVEST ApS Bankrupt 19 Dec 2014
- 1414 INVEST ApS Bankrupt 22 Dec 2015
- 1WAY2PRINT A/S Bankrupt 24 Jul 2003
- 2 X KJAER DK ApS Bankrupt 18 Dec 2024
- 20220608 ApS Bankrupt 18 Jul 2022
- 23K ApS Bankrupt 17 Jan 2022
- 24237982 A/S Bankrupt 25 Apr 2012
- 2BU EJENDOMME ApS Bankrupt 11 Sep 2013
- 2BU HOLDING ApS Bankrupt 2 Oct 2013
- 2Tal enterprise A/S Bankrupt 28 Apr 2020
- 2V AMAGER SYD ApS Bankrupt 20 Dec 2000
- 3 SIGMA ApS Bankrupt 9 Jun 2005
- 30 08 61 71 ApS Bankrupt 1 Dec 2011
- 31. OKTOBER 2008 ApS Bankrupt 18 Sep 2009
- 32 67 71 93 ApS Bankrupt 16 Nov 2011
- 36087374 ApS Bankrupt 10 Jan 2017
- 365 Service Holding ApS Bankrupt 26 Nov 2020
- 365 Service Partner ApS Bankrupt 26 Nov 2020
- 39701804 ApS Bankrupt 14 Aug 2020
- 39704994 ApS Bankrupt 14 Aug 2020
- 3BH ApS Bankrupt 3 May 2019
- 3XE BYG ApS Bankrupt 11 Aug 2017
Kirsten Aarup Drejer – 15 other companies, of which 2 bankrupt
- Selskabet af marts 2021 A/S Bankrupt 6 Apr 2021
- ULL CARE A/S Bankrupt 10 Jun 2022
- A/S HANSEN & JACOBSEN. TØMRER- OG SNEDKERFIRMA Active
- Antag Therapeutics ApS Active
- BIONEER A/S Active
- BIOPORTO A/S Active
- CURASIGHT A/S Active
- ENTELEKHEIA A/S Opløst
- Fructibio ApS Active
- Fructibio Holding ApS Active
- International N&H Denmark ApS Active
- KD INVEST ApS Active
- PROLIFERON ApS Opløst
- ResoTher Pharma A/S Active
- ZEALAND PHARMA A/S Active
Address history (5 moves)
| Pederstrupvej 93, 2750 Ballerup | |
| Pederstrupvej 93, 2750 Ballerup | |
| c/o c/o Bygning 375, Elektrovej 375, 2800 Kgs.Lyngby | |
| Agern Alle 1, 2970 Hørsholm | |
| Fannys Alle 11, 2900 Hellerup | |
| c/o Advokatfirmaet Stakemann, Kronprinsessegade 18, 1306 København K |
Former names
| Servier Symphogen A/S | – now |
| SYMPHOGEN A/S | – |
| THERAMAB ApS | – |
| ApS KBUS 38 NR. 3869 | – |
Employees per year
Other companies at the same address
- NEUROSCREEN ApS Opløst
- SERVIER DANMARK A/S Active
Similar companies in Ballerup
- ORIGIO A/S Ballerup
- SOPHION BIOSCIENCE A/S Ballerup
- PhageMind ApS Ballerup
- Dragonfly Therapeutics CPH ApS Ballerup
- Chip Diagnostics ApS Ballerup
- Qlife ApS Ballerup
- ME Brolægning ApS Ballerup
- ESTIBIO ApS Ballerup
- ATONOMICS A/S Ballerup
- NSGENE A/S Ballerup
Questions and answers about Servier Symphogen A/S
Has Servier Symphogen A/S gone bankrupt?
No, Servier Symphogen A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Servier Symphogen A/S?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the auditor of Servier Symphogen A/S?
Servier Symphogen A/S most recently used EY Godkendt Revisionspartnerselskab.
When was Servier Symphogen A/S founded?
Servier Symphogen A/S was founded on 1 January 2000.
What is the equity of Servier Symphogen A/S?
Equity was DKK 162.9m according to the annual report for the period ending 30 September 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.